New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
CNASRegulated (List II)

EBASTA

10MG/Orodispersible Tablet/EBASTINE
MERINAL
ManufacturerVerified lab

MERINAL

Public retail price
234.96DZD

Identification

Active ingredient (INN)
EBASTINE
Internal code
01 A 056
Country of Origin
Algeria
Pharmaceutical form
Orodispersible Tablet
Prescription List
Regulated (List II)
Packaging
b/10 et b/30
EBASTA
Clinical View
CNAS
Regulated (List II)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS).

Ebastine has been investigated for the treatment of Urticaria.

Indications

Not Available

Mechanism of Action

Ebastine is a second-generation antihistamine that acts as a selective histamine H1-receptor antagonist to relieve allergic symptoms.

H1 receptor antagonist Humans.

Metabolism

Hover over products below to view reaction partners Ebastine 4-(4-tert-butylphenyl)-4-oxobutanal + Deslakylebastine.

Adverse Effects

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Alternatives